Search research articles
Contact Us
Filters
Showing results (31-40 of 508) with videos related to
Page
of 51
Sort By:
European Heart Journal
|
September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox, Ian Ford, Ph Gabriel Steg, et al.
International Journal of Cardiology
|
February 1, 2017
Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al
Karl Swedberg, Michael Böhm, Jeffrey S Borer, et al.
JACC. Heart Failure
|
March 7, 2015
Effect of ivabradine on early readmissions after hospitalization for worsening heart failure
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
BMJ Open
|
February 1, 2013
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
Thomas M Macdonald, Isla S Mackenzie, Li Wei, et al.
The American Journal of Medicine
|
February 19, 2018
The Reply
Paul R Kalra, Nicola Greenlaw, Ian Ford, et al.
Current Medical Research and Opinion
|
September 12, 2015
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients
Jennifer K Rogers, Adrian Kielhorn, Jeffrey S Borer, et al.
European Heart Journal
|
September 20, 2015
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Plos One
|
April 9, 2013
Outcomes of induction of labour in women with previous caesarean delivery: a retrospective cohort study using a population database
Sarah J Stock, Evelyn Ferguson, Andrew Duffy, et al.
The New England Journal of Medicine
|
September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failure
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Journal of the American College of Cardiology
|
May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study
Karl Swedberg, Michel Komajda, Michael Böhm, et al.
Page
of 51
Search research articles
Search
Showing results (31-40 of 508) with videos related to
Sort By:
Page
of 51
European Heart Journal
|
September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox, Ian Ford, Ph Gabriel Steg, et al.
International Journal of Cardiology
|
February 1, 2017
Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al
Karl Swedberg, Michael Böhm, Jeffrey S Borer, et al.
JACC. Heart Failure
|
March 7, 2015
Effect of ivabradine on early readmissions after hospitalization for worsening heart failure
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
BMJ Open
|
February 1, 2013
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
Thomas M Macdonald, Isla S Mackenzie, Li Wei, et al.
The American Journal of Medicine
|
February 19, 2018
The Reply
Paul R Kalra, Nicola Greenlaw, Ian Ford, et al.
Current Medical Research and Opinion
|
September 12, 2015
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients
Jennifer K Rogers, Adrian Kielhorn, Jeffrey S Borer, et al.
European Heart Journal
|
September 20, 2015
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Plos One
|
April 9, 2013
Outcomes of induction of labour in women with previous caesarean delivery: a retrospective cohort study using a population database
Sarah J Stock, Evelyn Ferguson, Andrew Duffy, et al.
The New England Journal of Medicine
|
September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failure
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Journal of the American College of Cardiology
|
May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study
Karl Swedberg, Michel Komajda, Michael Böhm, et al.
Page
of 51